Notice for lenacapavir (LEN) (Gilead Sciences Pty Ltd)
Active ingredients
lenacapavir (LEN)
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
Pre-exposure prophylaxis (PrEP) to prevent HIV-1 in adults and adolescents weighing at least 35 kg
Therapeutic area
Infectious diseases